A detailed history of Clarius Group, LLC transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Clarius Group, LLC holds 868 shares of IQV stock, worth $167,246. This represents 0.01% of its overall portfolio holdings.

Number of Shares
868
Holding current value
$167,246
% of portfolio
0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$206.81 - $251.55 $179,511 - $218,345
868 New
868 $205,000
Q1 2024

Apr 17, 2024

SELL
$208.23 - $259.1 $42,478 - $52,856
-204 Reduced 17.48%
963 $243,000
Q4 2023

Jan 29, 2024

SELL
$177.16 - $232.73 $55,451 - $72,844
-313 Reduced 21.15%
1,167 $270,000
Q3 2023

Oct 19, 2023

SELL
$196.75 - $231.96 $70,633 - $83,273
-359 Reduced 19.52%
1,480 $291,000
Q2 2023

Aug 09, 2023

BUY
$183.66 - $224.77 $34,160 - $41,807
186 Added 11.25%
1,839 $413,000
Q1 2023

Apr 17, 2023

BUY
$188.0 - $240.65 $4,512 - $5,775
24 Added 1.47%
1,653 $328,000
Q4 2022

Jan 25, 2023

BUY
$172.45 - $226.53 $9,312 - $12,232
54 Added 3.43%
1,629 $334,000
Q3 2022

Oct 24, 2022

BUY
$181.14 - $248.26 $4,528 - $6,206
25 Added 1.61%
1,575 $285,000
Q2 2022

Aug 10, 2022

BUY
$196.45 - $252.29 $4,125 - $5,298
21 Added 1.37%
1,550 $336,000
Q4 2021

Feb 02, 2022

BUY
$238.37 - $282.61 $33,133 - $39,282
139 Added 10.0%
1,529 $431,000
Q3 2021

Oct 18, 2021

BUY
$239.54 - $265.23 $23,714 - $26,257
99 Added 7.67%
1,390 $333,000
Q2 2021

Aug 06, 2021

BUY
$198.06 - $246.77 $5,941 - $7,403
30 Added 2.38%
1,291 $313,000
Q1 2021

Apr 27, 2021

BUY
$173.0 - $194.59 $10,726 - $12,064
62 Added 5.17%
1,261 $244,000
Q4 2020

Jan 15, 2021

BUY
$153.99 - $180.39 $184,634 - $216,287
1,199 New
1,199 $215,000

Others Institutions Holding IQV

About IQVIA HOLDINGS INC.


  • Ticker IQV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 185,740,000
  • Market Cap $35.8B
  • Description
  • IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...
More about IQV
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.